Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs56325371 | chr16:89595036 | T/A | 0.000303 | 177 | 28.58 | 25.53 | 19.2 | KM Plot |
PCPG | rs56346774 | chr2:127932551 | G/A | 4.49E-5 | 174 | 25.87 | 18.2 | 33.9 | KM Plot |
PCPG | rs56352308 | chr2:241526053 | A/T | 3.68E-5 | 177 | 25.97 | 20.2 | 10.3 | KM Plot |
PCPG | rs56362330 | chr10:50549658 | T/TA | 3.73E-6 | 177 | 24.53 | 34.37 | 25.17 | KM Plot |
PCPG | rs56374309 | chr6:26566887 | AGTGAC/A | 7.54E-7 | 176 | 10.68 | 35.32 | 24.52 | KM Plot |
PCPG | rs56379434 | chr7:105159461 | C/T | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs56381951 | chr2:2746073 | C/T | 3.49E-5 | 173 | 25.6 | 23.43 | 21.68 | KM Plot |
PCPG | rs56394020 | chr8:1756462 | G/C | 1.07E-5 | 176 | 25 | 28.17 | 25.17 | KM Plot |
PCPG | rs56399248 | chr2:61558615 | T/G | 0.000452 | 178 | 24.1 | 30.93 | 17.85 | KM Plot |
PCPG | rs56412918 | chr2:61595416 | A/G | 6.44E-5 | 177 | 24.1 | 30.93 | 10.3 | KM Plot |
PCPG | rs56667361 | chr16:1679264 | AC/A | 0 | 175 | 25.47 | 22.77 | 2.93 | KM Plot |
PCPG | rs56781814 | chr7:33707590 | T/TTGTGTG | 1.43E-7 | 174 | 25.4 | 25.43 | 19.87 | KM Plot |
PCPG | rs56783920 | chr2:241532620 | C/A | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs56864106 | chr16:90125958 | C/T | 8.74E-9 | 176 | 25.87 | 20.2 | 6.62 | KM Plot |
PCPG | rs568992 | chr13:37515947 | G/A | 4.51E-5 | 176 | 56.35 | 24.17 | 25.7 | KM Plot |